NO168037C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive purin-derivater. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive purin-derivater.

Info

Publication number
NO168037C
NO168037C NO88884830A NO884830A NO168037C NO 168037 C NO168037 C NO 168037C NO 88884830 A NO88884830 A NO 88884830A NO 884830 A NO884830 A NO 884830A NO 168037 C NO168037 C NO 168037C
Authority
NO
Norway
Prior art keywords
preparation
therapeutic active
analogy procedure
purin derivatives
purin
Prior art date
Application number
NO88884830A
Other languages
English (en)
Other versions
NO884830D0 (no
NO168037B (no
NO884830L (no
Inventor
Robert Wilson Lambert
Joseph Armstrong Martin
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878725466A external-priority patent/GB8725466D0/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO884830D0 publication Critical patent/NO884830D0/no
Publication of NO884830L publication Critical patent/NO884830L/no
Publication of NO168037B publication Critical patent/NO168037B/no
Publication of NO168037C publication Critical patent/NO168037C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO88884830A 1987-10-30 1988-10-28 Analogifremgangsmaate ved fremstilling av terapeutisk aktive purin-derivater. NO168037C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878725466A GB8725466D0 (en) 1987-10-30 1987-10-30 Purine derivatives
GB888816612A GB8816612D0 (en) 1987-10-30 1988-06-13 Purine derivatives

Publications (4)

Publication Number Publication Date
NO884830D0 NO884830D0 (no) 1988-10-28
NO884830L NO884830L (no) 1989-05-02
NO168037B NO168037B (no) 1991-09-30
NO168037C true NO168037C (no) 1992-01-08

Family

ID=26292971

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88884830A NO168037C (no) 1987-10-30 1988-10-28 Analogifremgangsmaate ved fremstilling av terapeutisk aktive purin-derivater.

Country Status (15)

Country Link
EP (1) EP0314011A3 (no)
JP (1) JPH01149797A (no)
CN (1) CN1038102A (no)
AU (1) AU2416088A (no)
CS (1) CS270249B2 (no)
DK (1) DK603788A (no)
FI (1) FI884954A (no)
HU (1) HU199502B (no)
IL (1) IL88138A0 (no)
MC (1) MC1984A1 (no)
NO (1) NO168037C (no)
NZ (1) NZ226672A (no)
PH (1) PH25577A (no)
PT (1) PT88891B (no)
YU (1) YU199688A (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5310732A (en) * 1986-02-03 1994-05-10 The Scripps Research Institute 2-halo-2'-deoxyadenosines in the treatment of rheumatoid arthritis
US5106837A (en) * 1988-03-16 1992-04-21 The Scripps Research Institute Adenosine derivatives with therapeutic activity
US4908440A (en) * 1987-11-12 1990-03-13 Bristol Myers Company 2',3'-dideoxy-2'-fluoroarabinopyrimidine nucleosides
US4997926A (en) * 1987-11-18 1991-03-05 Scripps Clinic And Research Foundation Deaminase-stable anti-retroviral 2-halo-2',3'-dideoxy
ATE128141T1 (de) * 1988-03-16 1995-10-15 Scripps Research Inst Als therapeutische mittel verwendbare substituierte adeninderivate.
GR1000618B (el) * 1989-03-17 1992-08-31 Oncogen Μεθοδος αναστολης hiv χρησιμοποιωντας συνεργιστικους συνδυασμους νουκλεοσιδικων παραγωγων.
US5034518A (en) * 1989-05-23 1991-07-23 Southern Research Institute 2-fluoro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl) adenine nucleosides
US5384310A (en) * 1989-05-23 1995-01-24 Southern Research Institute 2'-fluoro-2-haloarabinoadinosines and their pharmaceutical compositions
HU906976D0 (en) * 1989-11-13 1991-05-28 Bristol Myers Squibb Co Process for producing 2', 3'-didesoxy-2'-fluoarabinonucleoside analogues
AU2001238516B2 (en) * 2000-02-18 2005-08-04 Southern Research Institute Methods for synthesizing 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H- purin-6-amine
US6753322B2 (en) 2000-06-06 2004-06-22 Pfizer Inc 2-aminocarbonyl-9H-purine derivatives
US7528247B2 (en) 2001-08-02 2009-05-05 Genzyme Corporation Process for preparing purine nucleosides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340645C (en) * 1987-04-17 1999-07-13 Victor E. Marquez Acid stable dideoxynucleosides active against the cytopathic effects of human immunodeficiency virus

Also Published As

Publication number Publication date
DK603788A (da) 1989-05-01
PH25577A (en) 1991-08-08
CN1038102A (zh) 1989-12-20
NO884830D0 (no) 1988-10-28
MC1984A1 (fr) 1989-11-23
PT88891B (pt) 1993-01-29
NZ226672A (en) 1991-07-26
DK603788D0 (da) 1988-10-28
NO168037B (no) 1991-09-30
YU199688A (en) 1990-04-30
CS270249B2 (en) 1990-06-13
IL88138A0 (en) 1989-06-30
FI884954A (fi) 1989-05-01
NO884830L (no) 1989-05-02
EP0314011A3 (de) 1990-04-11
HUT48270A (en) 1989-05-29
JPH01149797A (ja) 1989-06-12
HU199502B (en) 1990-02-28
CS705788A2 (en) 1989-10-13
EP0314011A2 (de) 1989-05-03
FI884954A0 (fi) 1988-10-27
AU2416088A (en) 1989-05-04

Similar Documents

Publication Publication Date Title
NO171506C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive adenosin-derivater
NO883974L (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO871266D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO159089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater.
NO870526L (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO884231D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazopyridin-derivater.
NO874032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO166083C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater.
NO165841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater.
NO171507C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nukleotidderivater
NO171412C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater
NO172489C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO875488D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO168037C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive purin-derivater.
NO164020C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater.
NO167287C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-isoxazol-beta-carboliner.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO169007C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive uridinderivater
NO171065C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater
NO172643C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzopyranolderivater
NO884175D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
NO891114D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater.
NO171501C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-metoksymetylpenem-derivater
NO171016C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive quinolin-derivater
NO167802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.